UNICYCIVE THERAPEUTICS INC (UNCY) Stock Income Statement
NASDAQ:UNCY - Nasdaq - US90466Y1038 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 675.00K | 950.00K | 0.00 | 0.00 | |||
| Operating Expenses | 32.12M | 21.45M | 19.00M | 8.98M | 2.02M | |||
| Research and Development | 20.01M | 12.90M | 12.44M | 6.08M | 1.02M | |||
| Selling, General, and Administrative Expenses | 12.10M | 8.55M | 6.57M | 2.90M | 1.01M | |||
| Operating Income | -32.12M | -20.77M | -18.05M | -8.98M | -2.02M | |||
| Interest Income/Expense | 1.19M | 533.00K | -10.00K | -630.00K | -240.00K | |||
| Other Income/Expense | -5.80M | -10.30M | 0.00 | -430.00K | 0.00 | |||
| Non Recurring Items | N/A | N/A | 0.00 | 20.00K | 0.00 | |||
| Income Before Taxes | -36.73M | -30.54M | -18.06M | -10.02M | -2.26M | |||
| Net Income | -37.82M | -31.41M | -18.06M | -10.02M | -2.26M | |||
| EBITDA | -31.69M | -20.49M | -18.04M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.65 | -12.80 | -11.99 | -6.68 | -1.55 | |||
| Non GAAP EPS | -10.70 | -16.10 | -12.00 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | -4653.48% | -1901.05% | N/A | N/A | |||
| Operating Profit Margin | N/A | -3077.63% | -1900.00% | N/A | N/A | |||
All data in USD